Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02065375
Recruitment Status : Completed
First Posted : February 19, 2014
Last Update Posted : November 6, 2014
Sponsor:
Collaborator:
AbbVie
Information provided by (Responsible Party):
Reata Pharmaceuticals, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2014
  Actual Study Completion Date : September 2014
  Certification/Extension First Submitted : October 22, 2014